Anfield Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.33K | Hold |
301
| – | – | ﹤0.01% | 335 |
|
|
2025
Q1 | $6.25K | Hold |
301
| – | – | ﹤0.01% | 303 |
|
|
2024
Q4 | $7.09K | Hold |
301
| – | – | ﹤0.01% | 273 |
|
|
2024
Q3 | $7.71K | Hold |
301
| – | – | ﹤0.01% | 264 |
|
|
2024
Q2 | $7.07K | Buy |
301
+1
| +0.3% | +$23 | ﹤0.01% | 222 |
|
|
2024
Q1 | $8.63K | Buy |
+300
| New | +$8.63K | ﹤0.01% | 163 |
|
|
2022
Q1 | – | Sell |
-12,535
| Closed | -$768K | – | 99 |
|
|
2021
Q4 | $768K | Buy |
12,535
+147
| +1% | +$9.01K | 0.26% | 50 |
|
|
2021
Q3 | $926K | Sell |
12,388
-114
| -0.9% | -$8.52K | 0.29% | 59 |
|
|
2021
Q2 | $1.16M | Buy |
12,502
+702
| +6% | +$65K | 0.44% | 45 |
|
|
2021
Q1 | $1.05M | Sell |
11,800
-17,310
| -59% | -$1.54M | 0.42% | 54 |
|
|
2020
Q4 | $2.72M | Sell |
29,110
-3,520
| -11% | -$328K | 1.16% | 23 |
|
|
2020
Q3 | $2.08M | Buy |
+32,630
| New | +$2.08M | 1.2% | 20 |
|
|
2020
Q1 | – | Sell |
-600
| Closed | -$20K | – | 122 |
|
|
2019
Q4 | $20K | Buy |
+600
| New | +$20K | 0.01% | 271 |
|